ROMJ Rubicon Organics Inc.

TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · rubiconorganics.com

0.4550CAD-1.09%Mkt Cap: 22.39M $P/E: —3d ago

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers ca…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap22.39M USD

Enterprise Value29.68M USD

Revenue (TTM)46.78M USD

Gross Profit16.12M USD

Net Income (TTM)765.40K USD

Revenue/Share0.91 CAD

Last Price0.4550 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees263

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)4.14

PEG—

EV/EBITDA16.06

EV/Revenue0.63

P/S0.48

P/B0.73

EPS (TTM)-0.02

EPS (Forward)0.11

52W Range

0.370029% of range0.6600

52W High0.6600 CAD

52W Low0.3700 CAD

Profitability

Gross Margin37.24%

Oper. Margin3.66%

EBITDA Margin3.95%

Profit Margin1.77%

ROE2.39%

ROA1.57%

Growth

Revenue Growth23.10%

Earnings Growth-41.80%

Cash Flow & Leverage

Operating CF-2.21M USD

CapEx (TTM)6.13M USD

FCF Margin-12.04%

FCF Yield-25.15%

Net Debt7.28M USD

Net Debt/EBITDA3.94

Balance Sheet

Debt/Equity0.28

Current Ratio2.21

Quick Ratio0.80

Book Value/Sh0.63 CAD

Cash/Share0.08 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)1.150 CAD

Upside (mean)+152.7%

Target Range1.000 CAD – 1.300 CAD

1.000+152.7% to mean1.300

# Analysts2

Ownership

Shares Out.67.58M

Float39.50M

Insiders42.26%

Institutions3.36%

Short Interest

Short Ratio0.1d

Short % Out.0.02%

Shares Short10.96K

Short (prev mo.)52.85K

Technical

SMA 500.4888 (-6.9%)

SMA 2000.4807 (-5.3%)

Beta0.43

S&P 52W Chg14.58%

Avg Vol (30d)84.78K

Avg Vol (10d)22.84K

Technical Indicators

RSI (14)44.8

MACD-0.0059

MACD Signal-0.0040

MACD Hist.-0.0019

BB Upper0.5009 CAD

BB Middle0.4726 CAD

BB Lower0.4444 CAD

BB Width11.96%

ATR (14)0.0222 CAD

Vol Ratio (20d)0.02x